Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
Matthew S McKinney, Anne W Beaven Division of Hematologic Malignancies, Department of Medicine, Duke University Medical Center, Durham, NC, USA Abstract: Most cases of indolent non-Hodgkin lymphoma (NHL) are incurable with standard chemoimmunotherapy approaches, and patients with relapsed/refracto...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-08-01
|
| Series: | Blood and Lymphatic Cancer : Targets and Therapy |
| Online Access: | http://www.dovepress.com/yttrium-90-ibritumomab-tiuxetan-in-the-treatment-of-non-hodgkin-lympho-peer-reviewed-article-BLCTT |